New patent expiration for Ge Healthcare drug VIZAMYL
Annual Drug Patent Expirations for VIZAMYL Vizamyl is a drug marketed by Ge Healthcare and is included in one NDA. […]
New patent expiration for Ge Healthcare drug VIZAMYL Read Post »
Patent Expiration
Drug Patent Expirations for the Week of January 15, 2023
LATISSE (bimatoprost) Allergan Patent: 8,758,733 Expiration: Jan 15, 2023 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of January 15, 2023 Read Post »
New patent expiration for Kyowa Kirin drug NOURIANZ
Annual Drug Patent Expirations for NOURIANZ Nourianz is a drug marketed by Kyowa Kirin and is included in one NDA.
New patent expiration for Kyowa Kirin drug NOURIANZ Read Post »
New patent expiration for Pfizer drug IBRANCE
Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It
New patent expiration for Allergan drug LATISSE
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Allergan and is included in one NDA. It
New patent expiration for Akarx Inc drug DOPTELET
Annual Drug Patent Expirations for DOPTELET Doptelet is a drug marketed by Akarx Inc and is included in one NDA.
New patent expiration for Akarx Inc drug DOPTELET Read Post »
New patent expiration for Allergan drug SAVELLA
Annual Drug Patent Expirations for SAVELLA Savella is a drug marketed by Allergan and is included in one NDA. It
New patent expiration for Sun Pharm drug WINLEVI
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA.
New patent expiration for Sun Pharm drug WINLEVI Read Post »
Drug Patent Expirations for the Week of January 8, 2023
OZURDEX (dexamethasone) Allergan Patent: 10,702,539 Expiration: Jan 9, 2023 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of January 8, 2023 Read Post »
